Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 17 Apr 2026 for Integrated Biopharma INC. Read the official filing
Filing timeline
BuySaleCarl Desantis
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carl Desantis: trading record in brief
This profile gathers the share dealings of Carl Desantis across 2 companies, led by Celsius Holdings, Inc. and Integrated Biopharma Inc. In total, 10 filings cover trades dated from 14 June 2021 to 15 April 2026.
Sales make up the whole of the open-market record (3 sales, €161.2M).
The newest entry dates from 17 April 2026: a transaction, in Integrated Biopharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Carl Desantis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
8,966,547 shares0Common StockSEC:0001102948-26-000002:0
2,235,417 shares0Common StockSEC:0001102948-26-000002:1
1,356,293 shares0Common StockSEC:0001102948-26-000001:0
771,047 shares0Common StockSEC:0001829126-23-003877:0
870,000 shares0Common StockSEC:0001829126-23-002061:0
3,952 shares@ US$102.470.1% of flowCommon StockSEC:0001829126-22-019260:0
96,501 shares@ US$103.433.1% of flowCommon StockSEC:0001829126-22-015173:0
60,000 shares0Common StockSEC:0001829126-22-002730:0
250,000 shares0Common StockSEC:0001829126-21-015544:0
2,928,310 shares@ US$62.5093.7% of flowCommon StockSEC:0001829126-21-005116:0
10 of 10 declarations
